COO

Nasdaq

COOPER COMPANIES, INC.

Health Care, Health Care Supplies

$74.23

close 7 Aug 2026

+4.73%

52-week change

$14.47B

market cap

$58.89

$89.83

52-week range

Valuation

Market cap$14.47B

P/E (TTM / 5y avg)63.44x41.79x

Forward P/E (FY2026 / FY2027)16.04x14.86x

PEG (TTM / fwd)—2.01

P/S (TTM)3.42x

P/B1.76x

EV/EBITDA (TTM)18.98x

FCF yield (TTM)3.94%

Cash flow & dividend

FCF (TTM)$569.50M

FCF per share (TTM)$2.92

FCF margin (TTM)13.46%

Dividend yield (indicated / 5y avg)—0.02%

Annualized dividend—

Payout ratio (EPS / FCF)0.00%0.00%

Growth & quality

Revenue YoY, latest Q+7.90%

Diluted EPS YoY, latest Q-190.91%

Operating margin (TTM)11.77%

Net margin (TTM)5.57%

ROE (latest FY)4.55%

Net debt / EBITDA (TTM)2.62

Interest coverage (TTM)5.35

Price

-32.05%-7.46%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +10.98%10Y CAGR +8.58%

Diluted EPS

5Y CAGR +9.23%10Y CAGR +6.09%

FCF per share

5Y CAGR +19.47%10Y CAGR +11.14%

Operating cash flow

5Y CAGR +10.35%10Y CAGR +7.37%

Free cash flow

5Y CAGR +19.74%10Y CAGR +11.36%

Dividends per share

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -0.05%10Y CAGR -0.04%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date25 Aug 2026

EPS estimate$1.13

Revenue estimate$1.11B

Last reported

Date—

EPS——

Revenue——